DAP:FRA
Danaher Corp
€201.90
arrow_downward
-0.83%(-1.70) 1D
Oct 20, 6:17:01 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
€198.50
High
€201.90
Low
€198.50
Mkt. cap
158.21B
Avg. vol.
338.00
Volume
85.00
52-wk high
€208.30
52-wk low
€137.80
No. of employees
59K
Open
€198.50
High
€201.90
Low
€198.50
Mkt. cap
158.21B
Avg. vol.
338.00
Volume
85.00
52-wk high
€208.30
52-wk low
€137.80
No. of employees
59K
News stories
From web sources and news partners
ad-hoc-news.de
·
1 hour ago
Danaher stock: At 7.19 percent below its 52-week high, Danaher stock sits at USD 225.35
Investing.com
·
2 hours ago
Danaher earnings on deck as new CEO faces bioprocessing test
ad-hoc-news.de
·
7 hours ago
Danaher schedules third-quarter results: Danaher stock is valued at USD 157.8 billion
ad-hoc-news.de
·
10 hours ago
Danaher Corp. stock: results due October 21, 2026 pre-market
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp